Professor Bruce Russell

2025

Journal - Research Article

Smith, A., Hariharan Nair, D., Smith, E. R., Wheeler, T. F., Smith, L. E., Russell, B. R., & Marra, C. A. (2025). University pharmacy clinic: Preventing errors and enhancing lives through expert medication management. Pharmacy, 13, 24. doi: 10.3390/pharmacy13010024

Shadli, S. M., Russell, B. R., Lodhia, V., Kirk, I. J., Glue, P., & McNaughton, N. (2025). Frontal localisation of a theory-based anxiety disorder biomarker: Goal conflict specific rhythmicity. Journal of Affective Disorders, 372, 287-295. doi: 10.1016/j.jad.2024.12.007

Journal - Research Other

Harrison, O. K., Köchli, L., Marino, S., Marlow, L., Finnegan, S. L., Ainsworth, B., … Russell, B. R., … Stephan, K. E. (2025). Gender differences in the association between anxiety and interoceptive insight. European Journal of Neuroscience, 61(1), e16672. doi: 10.1111/ejn.16672

2024

Journal - Research Article

Mitchell, M., Tomlinson, B. I., Egan, G. O., Huang, Y., Kellett, E. C., Rowley, G. P. F., Tang, S. I., Maindonald, Y. G., Logan, E. M., Russell, B. R., Bowden, N., & Harrison, O. K. (2024). Key factors related to happiness and anxiety in Aotearoa New Zealand during the COVID-19 pandemic. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1606), 73-91. Retrieved from https://www.nzmj.org.nz/

Shadli, S. M., Donegan, C. J., Mohd Fahmi, M. S. S. B., Russell, B. R., Glue, P., & McNaughton, N. (2024). Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression? Journal of Psychopharmacology. Advance online publication. doi: 10.1177/02698811241275627

Brand, K., Wise, T., Hess, A. J., Russell, B. R., Stephan, K. E., & Harrison, O. K. (2024). Incorporating uncertainty within dynamic interoceptive learning. Frontiers in Psychology, 15, 1254564. doi: 10.3389/fpsyg.2024.1254564

Journal - Research Other

Chin, P., Gorman, F., Beck, F., Russell, B. R., Stephan, K. E., & Harrison, O. K. (2024). A systematic review of brief respiratory, embodiment, cognitive and mindfulness interventions to reduce state anxiety. Frontiers in Psychology. Advance online publication. doi: 10.3389/fpsyg.2024.1412928

Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., … Layton, G., & Menkes, D. B. (2024). Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): Study protocol for a double-blind, randomised controlled trial. Trials, 25, 336. doi: 10.1186/s13063-024-08174-x

Conference Contribution - Published proceedings: Abstract

Cawood, S. M. F., Russell, B. R., Harrison, O. K., Williams, J. M., & Ryan, M. M. (2024). Plasma-derived microRNAs are altered with ketamine intervention for treatment-resistant generalised or social anxiety disorders. In K.-L. Horne (Ed.), Proceedings of the 40th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 63). Retrieved from https://www.awcbr.org

Cawood, T., Russell, B., Harrison, O., & Linscott, R. (2024). Neurobiology of psychosis risk. In K.-L. Horne (Ed.), Proceedings of the 40th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 59). Retrieved from https://www.awcbr.org

Shadli, S. M., Donegan, C., Russell, B. R., & McNaughton, N. (2024). Is lack of goal-conflict specific rhythmicity a biomarker for treatment resistance in generalized anxiety? In K.-L. Horne (Ed.), Proceedings of the 40th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 52). Retrieved from https://www.awcbr.org

Conference Contribution - Poster Presentation (not in published proceedings)

Gans, J., McLeod-Edwards, E., Gorman, F., Russell, B. R., & Harrison, O. K. (2024, August-September). SSRI effects on emotion recognition in anxiety. Poster session presented at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand.

Kemp, A. M., Glue, P., Russell, B. R., & Harrison, O. K. (2024, August-September). Amygdala connectivity during perception of emotional faces in individuals with treatment-refractory anxiety disorders. Poster session presented at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Paul, J., Russell, B. R., Turner, R., & Harrison, O. K. (2024, August-September). Investigating the effect of exercise on physiological and perceptual hypercapnic responses in anxiety. Verbal presentation at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand.

McLeod-Edwards, E., Gorman, F., Russell, B. R., & Harrison, O. K. (2024, August-September). Exploring the effect of SSRIs on interoceptive and exteroceptive perceptions in individuals with anxiety. Verbal presentation at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand.

Cawood, S. M. F., Williams, J. M., Ryan, M. M., Harrison, O. K., & Russell, B. R. (2024, August-September). Preliminary findings that Ketamine increases GABA levels in the amygdala two hours post infusion in people with treatment resistant anxiety. Verbal presentation at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand.

Cawood, T. J., Harrison, O. K., Linscott, R. J., & Russell, B. R. (2024, August-September). Investigating neurobiological correlates of Schizotypy using multimodal MRI in a subclinical cohort. Verbal presentation at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand.

2023

Journal - Research Article

Merritt, K., McCutcheon, R. A., Aleman, A., Ashley, S., Beck, K., Block, W., … Russell, B. R., … the 1H-MRS in Schizophrenia Investigators. (2023). Variability and magnitude of brain glutamate levels in schizophrenia: A meta and mega-analysis. Molecular Psychiatry, 28, 2039-2048. doi: 10.1038/s41380-023-01991-7

Conference Contribution - Published proceedings: Abstract

Cawood, T., Russell, B., Harrison, O., & Linscott, R. (2023). Altered brain morphology and chemistry correlates with augmented drug therapy for treatment-resistant schizophrenia. Proceedings of the Psycolloquy Symposium. (pp. 33). Dunedin, New Zealand: Department of Psychology, University of Otago. Retrieved from https://www.otago.ac.nz/psychology/research/otago059081.html

Kemp, A., Harrison, O., Russell, B., & Glue, P. (2023). Using neuroimaging to investigate functional connectivity alterations associated with anxiety. Proceedings of the Psycolloquy Symposium. (pp. 29). Dunedin, New Zealand: Department of Psychology, University of Otago. Retrieved from https://www.otago.ac.nz/psychology/research/otago059081.html

Buianova, I., Russell, B., & Pat, N. (2023). Exploring the predictive association between mental health and cognition in older adults from the UK Biobank cohort. In K.-L. Horne (Ed.), Proceedings of the 39th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 46). Retrieved from https://www.awcbr.org

Conference Contribution - Poster Presentation (not in published proceedings)

Cawood, S., Williams, J., Ryan, M., Russell, B., & Harrison, O. (2023, August). The neurobiology of anxiety, depression, and breathing-related catastrophising. Poster session presented at the Brain Health Research Centre (BHRC) Annual Conference, Dunedin, New Zealand.

McLeod-Edwards, E., Harrison, O., Russell, B., & Gorman, F. (2023, August). Exploring the effect of SSRIs on breathing-related interoception in individuals with anxiety. Poster session presented at the Brain Health Research Centre (BHRC) Annual Conference, Dunedin, New Zealand.

Other Research Output

Russell, B. R. (2023, July). Speed, addiction and psychosis. University of Otago, Dunedin, New Zealand. [Inaugural Professorial Lecture].

2022

Journal - Research Article

Harrison, O., Russell, B. R., & Pattinson, K. T. S. (2022). Perceptual and ventilatory responses to hypercapnia in athletes and sedentary individuals. Frontiers in Physiology, 13, 820307. doi: 10.3389/fphys.2022.820307

Maharjan, A., Peng, M., Russell, B., & Cakmak, Y. O. (2022). Investigation of the optimal parameters of median nerve stimulation using a variety of stimulation methods and its effects on heart rate variability: A systematic review. Neuromodulation, 25, 1268-1279. doi: 10.1016/j.neurom.2021.10.005

Conference Contribution - Published proceedings: Abstract

Cawood, T., Russell, B., & McIlwain, M. (2022). Valproate usage correlates with changes in brain volumes in ultra-treatment-resistant schizophrenia. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 86). Retrieved from https://www.queenstownresearchweek.org

Kemp, A., Pattinson, K., Glue, P., Russell, B., & Harrison, O. (2022). Assessing the relationship between sub-clinical anxiety and resting state functional connectivity. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 86). Retrieved from https://www.queenstownresearchweek.org

Cawood, S., Neehoff, S., Glue, P., Williams, J., Ryan, M., Russell, B., & Harrison, O. (2022). Investigating the relationship between microRNA expression, brain structure and biochemistry in anxiety disorders and their potential treatment with ketamine. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 82). Retrieved from https://www.queenstownresearchweek.org

Dawson, C., Schoss, S., Russell, B. R., Sellbom, M., & Harrison, O. (2022). Assessing the relationship between intrinsic motivations, personality traits and mental health. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 77). Retrieved from https://www.queenstownresearchweek.org

Harrison, O. K., Köchli, L., Marino, S., Marlow, L., Finnegan, S. L., Ainsworth, B., Russell, B. R., … Stephan, K. E. (2022). Anxiety is associated with interoceptive insight deficits in women but not men. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 39). Retrieved from https://www.queenstownresearchweek.org

Conference Contribution - Verbal presentation and other Conference outputs

Kemp, A., Pattinson, K., Glue, P., Russell, B., & Harrison, O. (2022, September). Assessing the relationship between sub-clinical anxiety and resting state functional connectivity. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand.

2021

Journal - Research Article

Shadli, S. M., Ando, L. C., McIntosh, J., Lodhia, V., Russell, B. R., Kirk, I. J., Glue, P., & McNaughton, N. (2021). Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports, 11, 19746. doi: 10.1038/s41598-021-99374-x

Merritt, K., McGuire, P. K., Egerton, A., and the 1H-MRS in Schizophrenia Investigators, including Russell, B. R. (2021). Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data. JAMA Psychiatry, 78(6), 667-681. doi: 10.1001/jamapsychiatry.2021.0380

Searchfield, G. D., Spiegel, D. P., Poppe, T. N. E. R., Durai, M., Jensen, M., Kobayashi, K., … Russell, B. R., … Wise, K. J. (2021). A proof-of-concept study comparing tinnitus and neural connectivity changes following multisensory perceptual training with and without a low-dose of fluoxetine. International Journal of Neuroscience, 131(5), 433-444. doi: 10.1080/00207454.2020.1746310

Ram, S., Russell, B. R., Stewart, K., Kirkpatrick, C., Henning, M., Scahill, S., & Hussainy, S. (2021). Psychiatrists’ attitudes towards and willingness to prescribe cognitive enhancers in academic settings. Drugs: Education, Prevention, & Policy, 28(1), 59-66. doi: 10.1080/09687637.2020.1735303

Journal - Research Other

Glue, P., Russell, B., & Medlicott, N. J. (2021). Influence of formulation and route of administration on ketamine's safety and tolerability: Systematic review. European Journal of Clinical Pharmacology, 77, 671-676. doi: 10.1007/s00228-020-03047-z

2020

Journal - Research Article

Ram, S., Russell, B., Kirkpatrick, C., Stewart, K., Scahill, S., Henning, M., … Hussainy, S. (2020). Professionals' attitudes towards the use of cognitive enhancers in academic settings. PLoS ONE, 15(11), e0241968. doi: 10.1371/journal.pone.0241968

McNabb, C. B., McIlwain, M. E., Anderson, V. M., Kydd, R. R., Sundram, F., & Russell, B. R. (2020). Aberrant white matter microstructure in treatment-resistant schizophrenia. Psychiatry Research: Neuroimaging, 305, 111198. doi: 10.1016/j.pscychresns.2020.111198

Sabrini, S., Russell, B., Wang, G. Y., Lin, J., Kirk, I., & Curley, L. (2020). Methamphetamine induces neuronal death: Evidence from rodent studies. NeuroToxicology, 77, 20-28. doi: 10.1016/j.neuro.2019.12.006

Searchfield, G. D., Poppe, T. N. E. R., Durai, M., Jensen, M., Kennedy, M. A., Maggo, S., Miller, A. L., … Russell, B. R., … Wise, K. (2020). A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity. International Journal of Neuroscience, 130(7), 671-682. doi: 10.1080/00207454.2019.1702544

Conference Contribution - Poster Presentation (not in published proceedings)

Russell, B. R., McNabb, C., McIlwain, M., Anderson, V., Sundram, F., & Kydd, R. (2020, June-July). White matter integrity in people with treatment-resistant schizophrenia. Poster session presented at the Organization for Human Brain Mapping (OHBM) 26th Annual Meeting, [Online].

2019

Chapter in Book - Research

McNabb, C. B., Smith, E. R., & Russell, B. R. (2019). Management of mental health disorders and the pharmacist's role: Schizophrenia. In Z. U.-D. Babar (Ed.), Encyclopedia of pharmacy practice and clinical pharmacy (Vol. 3: Part A). (1st ed.) (pp. 686-698). Amsterdam, The Netherlands: Elsevier. doi: 10.1016/B978-0-12-812735-3.00550-1

Journal - Research Article

Ram, S., Hussainy, S., Henning, M., Jensen, M., Stewart, K., & Russell, B. (2019). Cognitive enhancers (CE) and learning strategies. Journal of Cognitive Enhancement, 3(1), 124-130. doi: 10.1007/s41465-018-0089-9

Lagas, A. K., Black, J. M., Russell, B. R., Kydd, R. R., & Thompson, B. (2019). The effect of combined patching and citalopram on visual acuity in adults with amblyopia: A randomized, crossover, placebo-controlled trial. Neural Plasticity, 2019, 5857243. doi: 10.1155/2019/5857243

Spriggs, M. J., Thompson, C. S., Moreau, D., McNair, N. A., Wu, C. C., Lamb, Y. N., … Russell, B. R., … Kirk, I. J. (2019). Human sensory LTP predicts memory performance and is modulated by the BDNF Val⁶⁶Met polymorphism. Frontiers in Human Neuroscience, 13, 22. doi: 10.3389/fnhum.2019.00022

2018

Journal - Research Article

McNabb, C. B., Kydd, R., Sundram, F., Soosay, I., & Russell, B. R. (2018). Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia. Psychiatry Research: Neuroimaging, 283, 47-54. doi: 10.1016/j.pscychresns.2018.11.002

McNabb, C. B., Sundram, F., Soosay, I., Kydd, R. R., & Russell, B. R. (2018). Increased sensorimotor network connectivity associated with clozapine eligibility in people with schizophrenia. Psychiatry Research: Neuroimaging, 275, 36-42. doi: 10.1016/j.pscychresns.2018.02.008

Sengupta, N., McNabb, C. B., Kasabov, N., & Russell, B. R. (2018). Integrating space, time, and orientation in spiking neural networks: A case study on multimodal brain data modeling. IEEE Transactions on Neural Networks & Learning Systems, 29(11), 5249-5263. doi: 10.1109/TNNLS.2018.2796023

McNabb, C. B., Tait, R. J., McIlwain, M. E., Anderson, V. M., Suckling, J., Kydd, R. R., & Russell, B. R. (2018). Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia. Schizophrenia Research, 195, 160-167. doi: 10.1016/j.schres.2017.10.015

2017

Journal - Research Article

McIntosh, H. D., Russell, B. R., Cochran, J. R., & Sollers, III, J. J. (2017). The heart of the pressor effect: Acute caffeine ingestion and resting heart rate variability. Journal of Caffeine Research, 7(1), 23-30. doi: 10.1089/jcr.2016.0003

Ram, S., Hussainy, S., Henning, M., Stewart, K., Jensen, M., & Russell, B. (2017). Attitudes toward cognitive enhancer use among New Zealand tertiary students. Substance Use & Misuse, 52(11), 1387-1392. doi: 10.1080/10826084.2017.1281313

Journal - Professional & Other Non-Research Articles

Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Bimbaum, M. L., … Russell, B. R., … Correll, C. U. (2017). Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. American Journal of Psychiatry, 174(3), 216-229. doi: 10.1176/appi.ajp.2016.16050503

Conference Contribution - Published proceedings: Abstract

Curley, L. E., McNabb, C. B. C., Al-Attar, M., Bint, P., Bowers, T., Hinton, J., … Russell, B., … Cochran, J. (2017). Do cannabis users show differences in decision-making with risk- and reward-related processing? Proceedings of the Society for Neuroscience 47th Annual Meeting. 620.17/VV23. SfN. Retrieved from https://www.sfn.org/

Conference Contribution - Poster Presentation (not in published proceedings)

McNabb, C. B., Soosay, I., Sundram, F., Kydd, R., & Russell, B. (2017, June). Resting-state connectivity is associated with treatment response in people with schizophrenia. Poster session presented at the Organization for Human Brain Mapping (OHBM) 23rd Annual Meeting, Vancouver, Canada.

2016

Journal - Research Article

Lagas, A. K., Black, J. M., Byblow, W. D., Fleming, M. K., Goodman, L. K., Kydd, R. R., Russell, B. R., … Thompson, B. (2016). Fluoxetine does not enhance visual perceptual learning and triazolam specifically impairs learning transfer. Frontiers in Human Neuroscience, 10, 532. doi: 10.3389/fnhum.2016.00532

McGregor, A. L., Dysart, J., Tingle, M. D., Russell, B. R., Kydd, R. R., & Finucane, G. (2016). Varenicline improves motor and cognitive symptoms in early Huntington’s disease. Neuropsychiatric Disease & Treatment, 12, 2381-2386. doi: 10.2147/NDT.S111083

Lee, H., Wang, G. Y., Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography. Psychopharmacology, 233(15), 2869-2877. doi: 10.1007/s00213-016-4335-5

Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Using fMRI to compare the effects of benzylpiperazine with dexamphetamine: Their differences during the Stroop paradigm. Journal of Integrative Neuroscience, 15, 109. doi: 10.1142/S0219635216500084

Wang, G. Y., Kydd, R. R., & Russell, B. R. (2016). Quantitative EEG and low-resolution electromagnetic tomography (LORETA) imaging of patients undergoing methadone treatment for opiate addiction. Clinical EEG & Neuroscience, 47(3), 180-187. doi: 10.1177/1550059415586705

Ram, S., Hussainy, S., Henning, M., Jensen, M., & Russell, B. (2016). Prevalence of cognitive enhancer use among New Zealand tertiary students. Drug & Alcohol Review, 35(3), 345-351. doi: 10.1111/dar.12294

Lee, H., Wang, G. Y., Curley, L. E., Sollers, J. J., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: A single-dose study. Psychopharmacology, 233(5), 863-871. doi: 10.1007/s00213-015-4165-x

Doborjeh, M. G., Wang, G. Y., Kasabov, N. K., Kydd, R., & Russell, B. (2016). A spiking neural network methodology and system for learning and comparative analysis of EEG data from healthy versus addiction treated versus addiction not treated subjects. IEEE Transactions on Biomedical Engineering, 63(9), 1830-1841. doi: 10.1109/TBME.2015.2503400

Conference Contribution - Published proceedings: Abstract

Russell, B. R., McIlwain, M. E., Anderson, V., Kydd, R. R., & McNabb, C. B. (2016). Greater activity in the salience network of people with schizophrenia who respond to first-line antipsychotics. In B. Leitch (Ed.), Proceedings of the 34th International Australasian Winter Conference on Brain Research. (pp. 39). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr

2015

Journal - Research Article

Wang, G. Y., Kydd, R., Wouldes, T. A., Jensen, M., & Russell, B. R. (2015). Changes in resting EEG following methadone treatment in opiate addicts. Clinical Neurophysiology, 126(5), 943-950. doi: 10.1016/j.clinph.2014.08.021

Wang, G. Y., Kydd, R., & Russell, B. R. (2015). Auditory event-related potentials in methadone substituted opiate users. Journal of Psychopharmacology, 29(9), 983-995. doi: 10.1177/0269881115587929

Wang, G. Y., Kydd, R., & Russell, B. R. (2015). Resting EEG and ERPs findings in methadone-substituted opiate users: A review. Acta Neurologica Belgica, 115(4), 539-546. doi: 10.1007/s13760-015-0476-2

Turner, C. E., Russell, B. R., & Gant, N. (2015). Comparative quantification of dietary supplemented neural creatine concentrations with ¹H-MRS peak fitting and basis spectrum methods. Magnetic Resonance Imaging, 33(9), 1163-1167. doi: 10.1016/j.mri.2015.06.018

Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2015). Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers. Drug & Alcohol Dependence, 149, 122-127. doi: 10.1016/j.drugalcdep.2015.01.026

Curley, L. E., Kydd, R. R., Robertson, M. C., Pillai, A., McNair, N., Lee, H., … Russell, B. R. (2015). Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task: A pilot study. Psychopharmacology, 232(16), 2969-2980. doi: 10.1007/s00213-015-3933-y

Goldstein, M. E., Anderson, V. M., Pillai, A., Kydd, R. R., & Russell, B. R. (2015). Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia. International Journal of Neuropsychopharmacology, 18(6), pyu117. doi: 10.1093/ijnp/pyu117

Anderson, V. M., McIlwain, M. E., Kydd, R. R., & Russell, B. R. (2015). Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders? Psychiatry Research, 230(3), 811-818. doi: 10.1016/j.psychres.2015.10.036

Anderson, V. M., Goldstein, M. E., Kydd, R. R., & Russell, B. R. (2015). Extensive gray matter volume reduction in treatment-resistant schizophrenia. International Journal of Neuropsychopharmacology, 18(7), pyv016. doi: 10.1093/ijnp/pyv016

2014

Chapter in Book - Research

Dalley, J. W., & Russell, B. (2014). Molecular imaging studies in stimulant addiction: A cross-species perspective. In R. A. J. O. Dierckx, A. Otte, E. F. J. de Vries, A. van Waarde & J. A. den Boer (Eds.), PET and SPECT in psychiatry. (pp. 515-534). Berlin, Germany: Springer. doi: 10.1007/978-3-642-40384-2_22

Journal - Research Article

Wang, G. Y., Wouldes, T. A., Kydd, R., Jensen, M., & Russell, B. R. (2014). Neuropsychological performance of methadone-maintained opiate users. Journal of Psychopharmacology, 28(8), 789-799. doi: 10.1177/0269881114538541

Jan, R. K., Lin, J. C., McLaren, D. G., Kirk, I. J., Kydd, R. R., & Russell, B. R. (2014). The effects of methylphenidate on cognitive control in active methamphetamine dependence using functional magnetic resonance imaging. Frontiers in Psychiatry, 5, 20. doi: 10.3389/fpsyt.2014.00020

Conference Contribution - Published proceedings: Abstract

Lagas, A. K., Black, J., Stinear, C. M., Byblow, W. D., Phillips, G., Russell, B. R., Kydd, R. R., & Thompson, B. (2014). Can SSRIs enhance human visual cortex plasticity? In B. Leitch & J. Shemmell (Eds.), Proceedings of the 32nd International Australasian Winter Conference on Brain Research. 32, (pp. 74). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr

2013

Journal - Research Article

Young, S. A., Thrimawithana, T. R., Antia, U., Fredatovich, J. D., Na, Y., Neale, P. T., … Russell, B. (2013). Pharmaceutical quality of "party pills" raises additional safety concerns in the use of illicit recreational drugs. New Zealand Medical Journal, 126(1376). Retrieved from http://www.nzma.org.nz/journal

Wang, G. Y., Wouldes, T. A., & Russell, B. R. (2013). Methadone maintenance treatment and cognitive function: A systematic review. Current Drug Abuse Reviews, 6(3), 220-230. doi: 10.2174/18744737112059990020

Sun, Y., Evans, J., Russell, B., Kydd, R., & Connor, B. (2013). A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress. Neuropharmacology, 72, 20-28. doi: 10.1016/j.neuropharm.2013.04.021

Miles, S. W., Sheridan, J., Russell, B., Kydd, R., Wheeler, A., Walters, C., … Tiihonen, J. (2013). Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: A randomized, double-blind, placebo-controlled trial. Addiction, 108(7), 1279-1286. doi: 10.1111/add.12109

Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2013). Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI). Psychopharmacology, 229(4), 673-685. doi: 10.1007/s00213-013-3128-3

Journal - Research Other

Wilkins, C., Sheridan, J., Adams, P., Russell, B., Ram, S., & Newcombe, D. (2013). The new psychoactive substances regime in New Zealand: A different approach to regulation [Perspective]. Journal of Psychopharmacology, 27(7), 584-589. doi: 10.1177/0269881113491441

Wilkins, C., Sheridan, J., Adams, P., Russell, B., & Newcombe, D. (2013). Reply to Sumnall (2013): 'The New Zealand new psychoactive substances regime: A step in the right direction, but questions still remain'. Journal of Psychopharmacology, 27(11), 1078-1079. doi: 10.1177/0269881113503507a

Conference Contribution - Published proceedings: Abstract

Thompson, C. S., Collins, H., Antia, U., Shelling, A. N., Russell, B. R., Waldie, K. E., & Kirk, I. J. (2013). BDNF val66met polymorphism does not affect the FN400 evoked potential in human facial recognition memory. In B. Leitch & J. Shemmell (Eds.), Proceedings of the 31st International Australasian Winter Conference on Brain Research. 31, (pp. 49). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr/index.html

Lagas, A. K., Stinear, C. M., Byblow, W. D., Russell, B. R., Kydd, R. R., & Thompson, B. (2013). A short course of fluoxetine does not enhance visual perceptual learning in healthy adults. In B. Leitch & J. Shemmell (Eds.), Proceedings of the 31st International Australasian Winter Conference on Brain Research. 31, (pp. 40). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr

2012

Chapter in Book - Research

Lin, J. C., & Russell, B. R. (2012). Stimulants: Neuroimaging and treatments. In J. J. Canales (Ed.), Emerging targets for drug addiction treatment. (pp. 17-62). Nova Science.

Journal - Research Article

Ram, S., Russell, B., Gubb, M., Taylor, R., Butler, C., Khan, I., & Shelling, A. (2012). General practitioner attitudes to direct-to-consumer genetic testing in New Zealand. New Zealand Medical Journal, 125(1364), 14-26. Retrieved from http://www.nzma.org.nz/journal

McNabb, C. B., Russell, B. R., Caprioli, D., Nutt, D. J., Gibbons, S., & Dalley, J. W. (2012). Single chemical entity legal highs: Assessing the risk for long term harm. Current Drug Abuse Reviews, 5(4), 304-319. doi: 10.2174/1874473711205040005

Jan, R. K., Lin, J. C., Miles, S. W., Kydd, R. R., & Russell, B. R. (2012). Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sciences, 2(4), 553-572. doi: 10.3390/brainsci2040553

Jan, R. K., Kydd, R. R., & Russell, B. R. (2012). Functional and structural brain changes associated with methamphetamine abuse. Brain Sciences, 2(4), 434-482. doi: 10.3390/brainsci2040434

Journal - Research Other

Sheridan, J., Atmore, B., & Russell, B. (2012). New Zealand to establish fit for purpose regulation for new psychoactive substances. Addiction, 107(11), 1901-1902. doi: 10.1111/j.1360-0443.2012.03809.x

Conference Contribution - Published proceedings: Abstract

Collins, H., Thompson, C. S., Anita, U., Russell, B. R., Shelling, A. N., & Kirk, I. J. (2012). Evoked potential correlates of object recognition memory and the influence of the BDNF val66met polymorphism. In B. Leitch & J. Shemmell (Eds.), Proceedings of the 30th International Australasian Winter Conference on Brain Research. 30, (pp. 50). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr

Lagas, A. K., Stinear, C. M., Byblow, W. D., Russell, B. R., Kydd, R. R., & Thompson, B. (2012). Measurement of human visual cortex excitability using suprathreshold phosphene perception. In B. Leitch & J. Shemmell (Eds.), Proceedings of the 30th International Australasian Winter Conference on Brain Research. 30, (pp. 46). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr/index.html

2011

Journal - Research Article

McIlwain, M. E., Harrison, J., Wheeler, A. J., & Russell, B. R. (2011). Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatric Disease & Treatment, 7(1), 135-149. doi: 10.2147/NDT.S12769

Thornley, S., Russell, B., & Kydd, R. (2011). Carbohydrate reward and psychosis: An explanation for neuroleptic induced weight gain and path to improved mental health? Current Neuropharmacology, 9(2), 370-375. doi: 10.2174/157015911795596513

Lin, J. C., Jan, R. K., Lee, H., Jensen, M.-A., Kydd, R. R., & Russell, B. R. (2011). Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology, 214(3), 761-768. doi: 10.1007/s00213-010-2081-7

Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2011). Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination. Drug Testing & Analysis, 3(9), 582-585. doi: 10.1002/dta.285

Lee, H., Kydd, R. R., Lim, V. K., Kirk, I. J., & Russell, B. R. (2011). Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication. Psychopharmacology, 213(4), 707-714. doi: 10.1007/s00213-010-2025-2

2010

Journal - Research Article

Jan, R. K., Lin, J. C., Lee, H., Sheridan, J. L., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2010). Determining the subjective effects of TFMPP in human males. Psychopharmacology, 211(3), 347-353. doi: 10.1007/s00213-010-1911-y

Anita, U., Tingle, M. D., & Russell, B. R. (2010). Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans. Journal of Forensic Sciences, 55(5), 1311-1318. doi: 10.1111/j.1556-4029.2010.01457.x

2009

Journal - Research Article

Anita, U., Tingle, M. D., & Russell, B. R. (2009). 'Party pill' drugs: BZP and TFMPP. New Zealand Medical Journal, 123, 1307, 55-68.

Murphy, M., Antia, U., Chang, H.-Y., Han, J. Y., Ibrahim, A., Tingle, M., & Russell, B. (2009). Party pills and drug-drug interactions. New Zealand Medical Journal, 122(1293), 16-25. Retrieved from https://www.nzma.org.nz/journal

Lin, J. C., Bangs, N., Lee, H., Kydd, R. R., & Russell, B. R. (2009). Determining the subjective and physiological effects of BZP on human females. Psychopharmacology, 207(3), 439-446. doi: 10.1007/s00213-009-1669-2

Antia, U., Tingle, M. D., & Russell, B. R. (2009). Metabolic interactions with piperazine-based 'party pill' drugs. Journal of Pharmacy & Pharmacology, 61(7), 877-882. doi: 10.1211/jpp/61.07.0006

Antia, U., Tingle, M. D., & Russell, B. R. (2009). In vivo interactions between BZP and TFMPP (party pill drugs). New Zealand Medical Journal, 122(1303), 29-38. Retrieved from https://www.nzma.org.nz/journal

Antia, U., Lee, H. S., Kydd, R. R., Tingle, M. D., & Russell, B. R. (2009). Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Science International, 186(1-3), 63-67. doi: 10.1016/j.forsciint.2009.01.015

2007

Journal - Research Article

Sheridan, J., Butler, R., Wilkins, C., & Russell, B. (2007). Legal piperazine-containing party pills: A new trend in substance misuse. Drug & Alcohol Review, 26(3), 335-343. doi: 10.1080/09595230701255791

2006

Journal - Research Other

Hardy, I., Alany, R., Russell, B., & Hardy, G. (2006). Antimicrobial effects of arginine and nitrogen oxides and their potential role in sepsis [Editorial]. Current Opinion in Clinical Nutrition & Metabolic Care, 9(3), 225-232. doi: 10.1097/01.mco.0000222104.23171.58

2001

Journal - Research Article

Russell, B. R., & Laverty, R. (2001). The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity and neurotoxicity. Pharmacology Biochemistry & Behavior, 68(3), 565-574. doi: 10.1016/S0091-3057(01)00454-3

2000

Journal - Research Article

Russell, B. R., & Laverty, R. (2000). Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021. Annals of the New York Academy of Sciences, 914, 208-214. doi: 10.1111/j.1749-6632.2000.tb05197.x

1998

Conference Contribution - Published proceedings: Abstract

Laverty, R., Russell, B. R., & Zheng, Y. (1998). Mechanisms of neurotoxicity of substituted amphetamines. Toxicology Letters, 95(Suppl. 1), (pp. 119). doi: 10.1016/S0378-4274(98)80474-8

1997

Journal - Research Article

Zheng, Y., Russell, B., Schmierer, D., & Laverty, R. (1997). The effects of aminorex and related compounds on brain monoamines and metabolites in CBA mice. Journal of Pharmacy & Pharmacology, 49(1), 89-96. doi: 10.1111/j.2042-7158.1997.tb06758.x

1995

Journal - Research Article

Russell, B. R., Beresford, R. A., Schmierer, D. M., McNaughton, N., & Clark, C. R. (1995). Stimulus properties of some analogues of 4-methylaminorex. Pharmacology Biochemistry & Behavior, 51(2-3), 375-378. doi: 10.1016/0091-3057(94)00407-A